Search

everythinglearnresearchcommunity

for

Search:↓

A genetic marker linked to a type of hair loss was found in most patients studied.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

CRPS I is complex, linked to immune and nerve issues, and needs comprehensive treatment.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Daily intake of 0.5 or 5 mg cobalt ferrite nanoparticles can harm lungs through oxidative and inflammatory stress.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Mercury allergy linked to specific genes may contribute to burning mouth syndrome, and silicon might play a role in maintaining healthy hair.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Genetic factors, skin barrier, immune function, and obesity influence risk of fungal skin infections.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Modified liposomes with exosomes effectively deliver RNA to stem cells.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Genetic differences affect COVID-19 severity and treatment development.